Show and Tell: ClearUP Sinus Pain Relief Device

source: GritDaily

Stuffy sinus season is upon us. Spring comes around, and pollen casts a shadow on the beautiful weather. Somehow, tiny particles give us headaches, congestion, sinus pressure, and more. Spring 2020 was worse because many of us couldn’t decide if we had seasonal allergies or COVID-19. But for those who really do just have allergic rhinitis, you’ll be pleased to know there’s a handy device to clear up your sinus anytime, anywhere.

In this episode of my new series “Show and Tell”, I’m unboxing the ClearUP Sinus Pain Relief Device. This piece of tech won an innovation award, “Last Gadget Standing,” at the CES show in Las Vegas.

Sinus relief anytime, anywhere

On the rise, are FDA-cleared wearable and handheld devices that provide some treatment and don’t use any medicinal drugs or have chemical side effects. The ClearUP is a bioelectronic therapy device that creates and sends microcurrents to stimulate the nerves underlying the sinus area of your face. Once you wave the device on the cheek, nose, and brow bone–it releases the microcurrents directly into your skin to relieve the pain and pressure. The treatments last only five minutes, and as a drug-free handheld device, it can be used several times throughout the day if needed. It is FDA cleared is portable for easy use during travel. Just charge it through a USB cord, and it will last for six hours. Let those currents dissolve that pressure!

Clearing the path for medical innovations

The ClearUP Sinus Pain Relief device received recognition for its cutting edge technology. The technology isn’t new, but it’s quickly gaining popularity. Experts predict that bioelectronic therapy tech is clearing a path for new medical innovations.

Compared with more generic sinus treatment options–like nasal flushes or nose sprays and even pills–ClearUP is the only non-invasive option. Created by Tivic Health, this device is a trailblazer in this space and setting a new standard for sinus pain relief.

Listen to this article or watch the coverage.